Raras
Buscar doenças, sintomas, genes...
Síndrome de poiquilodermia fibrosante hereditária-contraturas-miopatia-fibrose pulmonar
ORPHA:221043CID-10 · Q82.8OMIM 615704DOENÇA RARA

A síndrome de poiquilodermia hereditária fibrosante-contraturas de tendão-miopatia-fibrose pulmonar é uma síndrome de poiquilodermia hereditária rara, genética, caracterizada por poiquilodermia de início precoce (principalmente na face), hipotricose, hipoidrose, contraturas musculares e tendinosas com deformidade em varo do pé, fraqueza muscular proximal e distal progressiva em todas as extremidades e fibrose pulmonar progressiva. Linfedema leve das extremidades, retardo de crescimento, comprometimento hepático, insuficiência pancreática exócrina e anormalidades hematológicas são características variáveis ​​adicionais.

Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

📋

A síndrome de poiquilodermia hereditária fibrosante-contraturas de tendão-miopatia-fibrose pulmonar é uma síndrome de poiquilodermia hereditária rara, genética, caracterizada por poiquilodermia de início precoce (principalmente na face), hipotricose, hipoidrose, contraturas musculares e tendinosas com deformidade em varo do pé, fraqueza muscular proximal e distal progressiva em todas as extremidades e fibrose pulmonar progressiva. Linfedema leve das extremidades, retardo de crescimento, comprometimento hepático, insuficiência pancreática exócrina e anormalidades hematológicas são características variáveis ​​adicionais.

Escala de raridade

CLASSIFICAÇÃO ORPHANET · BRASIL 2024
<1 / 1 000 000
Ultra-rara
<1/50k
Muito rara
1/20k
Rara
1/10k
Pouco freq.
1/5k
Incomum
1/2k
Prevalência
0.0
Worldwide
Casos conhecidos
15
pacientes catalogados
Início
Infancy
🏥
SUS: Cobertura mínimaScore: 15%
CID-10: Q82.8
🇧🇷Dados SUS / DATASUS
PROCEDIMENTOS SIGTAP (5)
0202010503
Cariótipo — bandas G, Q ou Rgenetic_test
0202010600
Pesquisa de microdeleções/microduplicações por FISHlab_test
0202010694
Sequenciamento completo do exoma (WES)rehabilitation
0202010260
Dosagem de alfa-fetoproteína
0301070040
Atendimento em reabilitação — doenças raras
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Partes do corpo afetadas

💪
Músculos
3 sintomas
🦴
Ossos e articulações
3 sintomas
👁️
Olhos
3 sintomas
📏
Crescimento
2 sintomas
🧬
Pele e cabelo
1 sintomas
🫃
Digestivo
1 sintomas

+ 7 sintomas em outras categorias

Características mais comuns

100%prev.
Atrofia do músculo esquelético
Frequência: 4/4
100%prev.
Concentração elevada de creatina quinase circulante
Frequência: 3/3
100%prev.
Alopecia
Frequência: 8/8
100%prev.
Sobrancelha esparsa
Frequência: 8/8
100%prev.
Defeito ventilatório restritivo
Frequência: 5/5
100%prev.
Puberdade atrasada
Frequência: 2/2
21sintomas
Muito frequente (13)
Frequente (1)
Ocasional (6)
Sem dados (1)

Os sintomas variam de pessoa para pessoa. Abaixo estão as 21 características clínicas mais associadas, ordenadas por frequência.

Atrofia do músculo esqueléticoSkeletal muscle atrophy
Frequência: 4/4100%
Concentração elevada de creatina quinase circulanteElevated circulating creatine kinase concentration
Frequência: 3/3100%
Alopecia
Frequência: 8/8100%
Sobrancelha esparsaSparse eyebrow
Frequência: 8/8100%
Defeito ventilatório restritivoRestrictive ventilatory defect
Frequência: 5/5100%

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa1desde 2026
Últimos 10 anos200publicações
Pico202138 papers
Linha do tempo
2026Hoje · 2026📈 2021Ano de pico
Publicações por ano (últimos 10 anos)

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

Genes associados

1 gene identificado com associação a esta condição. Padrão de herança: Autosomal dominant.

FAM111BSerine protease FAM111BDisease-causing germline mutation(s) inModerado
FUNÇÃO

Serine protease

LOCALIZAÇÃO

MECANISMO DE DOENÇA

Poikiloderma, hereditary fibrosing, with tendon contractures, myopathy, and pulmonary fibrosis

An autosomal dominant form of hereditary poikiloderma, a genodermatosis characterized by mottled pigmentation, telangiectasia, and epidermal atrophy. POIKTMP features include tendon contracture, myopathy, and progressive pulmonary fibrosis. It manifests from early childhood with telangiectasia and pigmentary anomalies especially on the face and sun-exposed areas, tendon contractures that particularly involve the ankles and feet causing gait disturbance, and development of pulmonary fibrosis during the second decade of life resulting in progressive dyspnea and restrictive impairment of lung function.

EXPRESSÃO TECIDUAL(Tecido-específico)
Linfócitos
51.3 TPM
Fibroblastos
5.7 TPM
Esôfago - Mucosa
4.3 TPM
Intestino delgado
2.2 TPM
Baço
1.6 TPM
OUTRAS DOENÇAS (1)
hereditary sclerosing poikiloderma with tendon and pulmonary involvement
HGNC:24200UniProt:Q6SJ93

Variantes genéticas (ClinVar)

25 variantes patogênicas registradas no ClinVar.

🧬 FAM111B: GRCh37/hg19 11p11.12-q12.2(chr11:51183549-61422182)x3 ()
🧬 FAM111B: NM_198947.4(FAM111B):c.1880G>C (p.Arg627Thr) ()
🧬 FAM111B: GRCh37/hg19 11q12.1-13.3(chr11:56895955-69295402)x3 ()
🧬 FAM111B: GRCh37/hg19 11p11.12-q13.1(chr11:50398499-63924462)x3 ()
🧬 FAM111B: NM_198947.4(FAM111B):c.1997C>A (p.Thr666Asn) ()
Ver todas no ClinVar

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Síndrome de poiquilodermia fibrosante hereditária-contraturas-miopatia-fibrose pulmonar

🗺️

Selecione um estado ou use sua localização para ver resultados.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

Pesquisa e ensaios clínicos

Nenhum ensaio clínico registrado para esta condição.

🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Publicações mais relevantes

Timeline de publicações
0 papers (10 anos)
#1

A Diagnostic Dilemma: Concurrent Diagnosis of Cystic Fibrosis and Definitive Kabuki Syndrome Type 1.

International journal of molecular sciences2026 Mar 09

The article presents a clinical case involving a patient with presumptive coexistence of two hereditary disorders, confirmed by molecular genetic analyses. Clinical evaluation of the proband, a 9-year-old girl, revealed features characteristic of Kabuki syndrome, including a typical "Kabuki makeup" facial phenotype, short stature, intracranial hypertension, and diffuse muscular hypotonia. Additional clinical findings included chronic right-sided otitis media, conjunctivitis, recurrent pneumonia, bilateral conductive hearing loss, astigmatism, and primary adenitis. Clinical assessment and molecular genetic testing were performed. High-throughput sequencing identified a previously reported pathogenic heterozygous variant in the KMT2D gene, NM_003482.4:c.15142C>T p.Arg5048Cys, and two known heterozygous variants in the CFTR gene: NM_000492.4:c.1521_1523delCTT p.Phe508del and c.3454G>C p.Asp1152His, classified as pathogenic and of variable clinical significance, respectively. Segregation analysis demonstrated that the KMT2D variant most likely arose in the proband de novo, whereas the CFTR variants were inherited from each of the parents. Notably, the proband's clinically unaffected elder sister carried the same CFTR genotype. Based on the clinical presentation and molecular genetic findings, the diagnosis of Kabuki syndrome type 1 was conclusively established in the patient. Functional assessment of CFTR demonstrated its preserved function, which did not support a diagnosis of CF or CFTR-related disorders.

#2

Protective role of early Tnfsf15 upregulation in limiting glomerular injury and proteinuria in experimental Alport Syndrome.

Journal of pharmacological sciences2026 Mar

Alport syndrome is a progressive kidney disease caused by pathogenic variants in genes encoding type IV collagen, a major structural component of the glomerular basement membrane (GBM). Abnormal GBM architecture impairs filtration and triggers inflammation, fibrosis, and eventual kidney failure. Because disease progression is irreversible, identifying early molecular changes is essential for understanding disease onset. We performed glomerular single-cell RNA sequencing (scRNA-seq) in a Col4a5 G5X Alport mouse model at 5 weeks of age, prior to detectable proteinuria or GBM/podocyte abnormalities (pre-onset), and at 8 weeks, when mild proteinuria and structural defects emerged. Despite the early stage, scRNA-seq revealed widespread transcriptional alterations, most prominently in podocytes. Among genes upregulated at both time points, we identified Tumor Necrosis Factor Superfamily Member 15 (Tnfsf15), previously associated with kidney disease susceptibility but with unclear function. To determine its role in Alport syndrome, we generated Tnfsf15-deficient Alport mice. Tnfsf15 homozygous knockout mice exhibited increased proteinuria and exacerbated glomerular injury compared with Tnfsf15(+/+) Alport mice during early disease. These findings support a protective role for Tnfsf15 in the early stages of Alport syndrome, mitigating proteinuria and limiting glomerular injury.

#3

Horns, nails, and leaky kidneys: A rare case of congenital nephrotic syndrome.

Clinical nephrology. Case studies2026

Nail-patella syndrome (NPS) is an uncommon autosomal dominant condition marked by nail dysplasia, skeletal abnormalities, and variable renal manifestations, resulting from mutations in the LMX1B gene. We report a rare case of a 23-year-old male presenting with nephrotic-range proteinuria, characteristic skeletal manifestations of NPS, and a family history of renal failure. Genetic testing identified a previously unreported heterozygous missense variant in the homeodomain of LMX1B (c.791A>C; p.Gln264Pro), supporting its pathogenicity. The absence of patellar hypoplasia in our patient highlights the phenotypic variability of NPS. This case reinforces the importance of detailed physical examination and targeted genetic testing in diagnosing nephrotic syndromes.

#4

Alport Syndrome is a Partial Tubulointerstitial Disease of the Kidney.

Kidney international reports2026 Feb

Recent genetic studies have shown that Alport syndrome (AS) is much more prevalent than clinically recognized, suggesting that atypical cases may phenocopy other kidney diseases. To date, pathomechanistic studies of AS have focused exclusively on the glomerular membrane, yet equally strong expression of collagen α(IV) chains is found along the distal renal tubule. We hypothesized that genetically determined abnormality of the tubular collagen IV (α345) molecule contributes to kidney failure and may drive atypical phenotypes. Histology and primary tubular cells (PTCs) of 8 patients with AS were investigated alongside controls. Collagen α5 (IV) was detected within the tubular basement membrane (BM) (TBM) of the distal segments of renal tubules by immunohistochemistry. In situ hybridization on human tissues and protein detection of collagen α5 (IV) in PTC cultures clearly showed that the distal tubular apparatus predominantly produces collagen IV for the TBM. Electron microscopy of biopsies from patients with AS demonstrated irregularities of the TBM, somewhat similar as described for the glomerular BM (GBM). Finally, computer-assisted analyses showed that in biopsies of patients with AS, interstitial fibrosis preferentially occurs in spatial vicinity of the affected distal tubules. Our study demonstrates that the collagen IV (α345) molecule within the TBM is largely produced by the distal tubule itself. In AS, the TBM shows ultrastructural changes, which may induce fibrotic molecular signatures, as tubulointerstitial fibrosis appears to start in the vicinity of the distal tubule. Therefore, we postulate that the progression of kidney disease in AS may in part stem from the (distal) tubular apparatus.

#5

Non-Syndromic Hereditary Gingival Fibromatosis Driven by Chymase Deficiency Is Attenuated by Verteporfin-Loaded Exosomes.

Journal of clinical periodontology2026 Apr

To identify novel non-syndromic hereditary gingival fibromatosis (nsHGF)-associated pathogenic variants and discover therapeutic targets for innovative, minimally invasive therapies. Whole-genome sequencing was performed to identify the pathogenic variant in a family with nsHGF. Levels of fibrosis markers and the yes-associated protein/transcriptional coactivator with PDZ-binding motif (YAP/TAZ) in gingival fibroblasts were measured by qPCR, western blot and immunofluorescence. Conditioned medium from gingival fibroblasts was used to treat THP-1-derived macrophages. In vivo pro-fibrotic behaviour of CHYMASE-silenced gingival fibroblasts and verteporfin-loaded exosome efficacy were evaluated in NOD/SCID mice. We identified a novel CHYMASE (CMA1) nonsense mutation (c.114C>A, p.Tyr38*) in the nsHGF family. This mutation caused chymase deficiency in the patient's gingival fibroblasts, directly leading to extracellular matrix (ECM) overproduction through YAP/TAZ activation. Moreover, CHYMASE-silenced gingival fibroblasts promoted interleukin-6 (IL-6) secretion by macrophages, thereby amplifying pro-fibrotic responses in gingival fibroblasts. The YAP inhibitor verteporfin suppressed ECM overproduction in CHYMASE-silenced gingival fibroblasts. In vivo, topical administration of verteporfin-loaded exosomes significantly attenuated chymase deficiency-induced fibrosis. Our findings support the pathogenic role of the CHYMASE mutation in nsHGF, establish chymase deficiency and consequent YAP/TAZ activation as the underlying mechanism and propose verteporfin-loaded exosomes as a promising therapeutic strategy for nsHGF-associated gingival overgrowth.

Publicações recentes

Ver todas no PubMed

📚 EuropePMCmostrando 200

2026

A Diagnostic Dilemma: Concurrent Diagnosis of Cystic Fibrosis and Definitive Kabuki Syndrome Type 1.

International journal of molecular sciences
2026

Horns, nails, and leaky kidneys: A rare case of congenital nephrotic syndrome.

Clinical nephrology. Case studies
2026

Protective role of early Tnfsf15 upregulation in limiting glomerular injury and proteinuria in experimental Alport Syndrome.

Journal of pharmacological sciences
2026

Alport Syndrome is a Partial Tubulointerstitial Disease of the Kidney.

Kidney international reports
2025

Anticodon-edited tRNA enables translational readthrough of COL4A5 premature termination codons.

PloS one
2026

Non-Syndromic Hereditary Gingival Fibromatosis Driven by Chymase Deficiency Is Attenuated by Verteporfin-Loaded Exosomes.

Journal of clinical periodontology
2025

Advances in research on congenital and hereditary intestinal diseases: From molecular mechanisms to precision medicine.

Intractable &amp; rare diseases research
2025

Senior-Løken syndrome with IQCB1/NPHP5 mutation in an adult: a case report.

Journal of medical case reports
2025

Case Report: autosomal dominant distal motor neuropathy as a new phenotype of KIF21A-related disorders.

Frontiers in genetics
2026

From RAAS blockade to regenerative medicine: evolving treatment strategies in Alport syndrome.

Pediatric nephrology (Berlin, Germany)
2026

Decoding VEXAS syndrome: emerging insights into pathogenesis and clinical management.

Current opinion in rheumatology
2025

Early-onset neutropenia and mixed phenotype in ADA2 deficiency: diagnostic and therapeutic challenges.

Frontiers in immunology
2025

An Integrative Genotyping and Gene Expression Profiling of the Mutated Human FAM111B Gene and Fibrosis-Associated Pathway in the POIKTMP Syndrome.

Journal of cellular and molecular medicine
2025

External Neurolysis and Hypothenar Fat Pad Flap With Early Nerve Gliding Exercise Regimen for Recurrent Carpal Tunnel Syndrome.

Cureus
2025

Serum Galectin-3 and Presepsin Levels in Pediatric Familial Mediterranean Fever Patients During Remission: A Prospective Study.

Diagnostics (Basel, Switzerland)
2026

Treatment Approaches for Alport Syndrome.

Journal of the American Society of Nephrology : JASN
2025

A rare case of dual glomerular pathology: Alport syndrome and immune complex-mediated MPGN.

BMC nephrology
2025

Perivascular inflammation in the progression of aortic aneurysms in Marfan syndrome.

JCI insight
2025

The Significance of the Presence of Gilbert's Syndrome in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A Retrospective Cohort Study.

Cureus
2025

[Myeloproliferative syndrome as a cause of chorea].

Medicina
2025

An engineered glutamic acid tRNA for efficient suppression of pathogenic nonsense mutations.

Nucleic acids research
2025

Nephronophthisis and Retinitis Pigmentosa (Senior-Loken Syndrome) After Living-Donor Kidney Transplantation: Twelve-Year Follow-Up in a Young Woman.

Journal of medical cases
2025

Dapagliflozin, in addition to ramipril, ameliorates kidney disease progression in mice with Alport syndrome.

American journal of physiology. Renal physiology
2025

Chemical chaperone 4-phenylbutyrate treatment alleviates the kidney phenotype in a mouse model of Alport syndrome with a pathogenic variant in Col4a3.

Kidney international
2025

Nonsense Mutations in Rare and Ultra-Rare Human Disorders: An Overview.

IUBMB life
2025

A novel mouse model for X-linked Alport syndrome induced by splicing mutation in the Col4a5 gene.

Scientific reports
2025

Atypical MEGDHEL Syndrome: A Milder Phenotype With Hepatic Presentation and Failure to Thrive Associated With a Homozygous Nonsense Variant of SERAC1.

JIMD reports
2025

Hydrogel Innovations in Biosensing: A New Frontier for Pancreatitis Diagnostics.

Bioengineering (Basel, Switzerland)
2025

Whole exome sequencing enhances diagnosis of hereditary bronchiectasis.

Orphanet journal of rare diseases
2025

Increased HA/CD44/TGFβ signaling implicates in renal fibrosis of a Col4a5 mutant Alport mice.

Molecular medicine (Cambridge, Mass.)
2025

Gynecological issues in children and adolescents seen at rare-disease referral centers: an observational retrospective cohort study.

Orphanet journal of rare diseases
2025

Genetic Mutations and Post-Lung Transplant Complications: A Case of Hereditary Transthyretin Amyloidosis.

Transplantation proceedings
2025

Genetic study on candidates for oocyte donation.

JBRA assisted reproduction
2025

Emerging concepts and treatments in autoinflammatory interferonopathies and monogenic systemic lupus erythematosus.

Nature reviews. Rheumatology
2025

Clinical, histological and receptor profiles of invasive breast cancer and ductal carcinoma in situ in females with germline pathogenic variants in PTEN and implications for germline testing.

Pathology
2024

Alport Syndrome With a Rare Collagen Type IV Alpha-4 (COL4A4) Gene Mutation: A Case Report.

Cureus
2024

Interdependence between Nuclear Pore Gatekeepers and Genome Caretakers: Cues from Genome Instability Syndromes.

International journal of molecular sciences
2024

Limited fasciectomy with versus without autologous adipose tissue grafting for treatment of Dupuytren's contracture (REMEDY): study protocol for a multicentre randomised controlled trial.

Trials
2024

Alpha-1 antitrypsin deficiency and Pi*Z allele as important co-factors in the development of liver fibrosis.

World journal of hepatology
2024

A pedigree analysis of Rotor hyperbilirubinemia combined with hepatitis B virus infection in a SLCO1B1 and SLCO1B3 gene mutations patient.

Heliyon
2024

Analyses of 1236 genotyped primary ciliary dyskinesia individuals identify regional clusters of distinct DNA variants and significant genotype-phenotype correlations.

The European respiratory journal
2024

Oral Health-Related Quality of Life in Rare Disorders of Congenital Facial Weakness.

International journal of environmental research and public health
2024

Tauroursodeoxycholic acid ameliorates renal injury induced by COL4A3 mutation.

Kidney international
2024

Metabolic Analysis and Renal Protective Effects of Linagliptin and Empagliflozin in Alport Syndrome.

Kidney360
2023

Systemic sclerosis associated myopathy: how to treat.

Current treatment options in rheumatology
2024

ANTXR1 deficiency promotes fibroblast senescence: implications for GAPO syndrome as a progeroid disorder.

Scientific reports
2024

Midfacial toddler excoriation syndrome (MiTES): case series, diagnostic criteria and evidence for a pathogenic mechanism.

The British journal of dermatology
2024

MRI evaluation of cranial nerve abnormalities and extraocular muscle fibrosis in duane retraction syndrome and congenital extraocular muscle fibrosis.

Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie
2024

A case of crescentic glomerulonephritis with exacerbation of pre-existing IgA nephropathy after COVID-19.

The Turkish journal of pediatrics
2024

Throwing off the keratin chains: a potential therapy for hereditary podocytopathy.

Kidney international
2024

PDGF-D Is Dispensable for the Development and Progression of Murine Alport Syndrome.

The American journal of pathology
2024

A Population-Based and Clinical Cohort Validation of the Novel Consensus Definition of Metabolic Hyperferritinemia.

The Journal of clinical endocrinology and metabolism
2024

[Lung involvement in autoinflammatory diseases].

Revue des maladies respiratoires
2023

Two sides of the same coin: a complex presentation of autosomal dominant tubulointerstitial kidney diseases: a literature review and case reports.

Frontiers in pediatrics
2024

Histologic characterization of primary ciliary dyskinesia chronic rhinosinusitis.

International forum of allergy &amp; rhinology
2024

The Functional Role of microRNAs and mRNAs in Diabetic Kidney Disease: A Review.

Current diabetes reviews
2023

Double heterozygous pathogenic mutations in KIF3C and ZNF513 cause hereditary gingival fibromatosis.

International journal of oral science
2024

Pathophysiologic implications of elevated prevalence of hereditary alpha-tryptasemia in all mastocytosis subtypes.

The Journal of allergy and clinical immunology
2024

Mitochondrial DNA 13513G>A Mutation Causing Leber Hereditary Optic Neuropathy Associated With Adult-Onset Renal Failure.

Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society
2023

Finerenone Added to RAS/SGLT2 Blockade for CKD in Alport Syndrome. Results of a Randomized Controlled Trial with Col4a3-/- Mice.

Journal of the American Society of Nephrology : JASN
2023

Risk factors and clinical features associated with basal ganglia manganese deposition in patients with hereditary hemorrhagic telangiectasia.

Clinical imaging
2023

A Treatment Approach in Congenital Fibrosis of Extraocular Muscles.

Medical archives (Sarajevo, Bosnia and Herzegovina)
2023

Dual inhibition of the endothelin and angiotensin receptor ameliorates renal and inner ear pathologies in Alport mice.

The Journal of pathology
2023

Repurposing small molecules for nephronophthisis and related renal ciliopathies.

Kidney international
2023

Targeting Fibrosis Pathways in Alport Syndrome-Is it Too Late?

Kidney360
2023

The CFTR Gene Germline Heterozygous Pathogenic Variants in Russian Patients with Malignant Neoplasms and Healthy Carriers: 11,800 WGS Results.

International journal of molecular sciences
2023

Ratio of Urinary Proteins to Albumin Excretion Shifts Substantially during Progression of the Podocytopathy Alport Syndrome, and Spot Urine Is a Reliable Method to Detect These Pathologic Changes.

Cells
2023

Emerging Personalized Opportunities for Enhancing Translational Readthrough in Rare Genetic Diseases and Beyond.

International journal of molecular sciences
2023

A common genetic variation in GZMB may associate with cancer risk in patients with Lynch syndrome.

Frontiers in oncology
2023

Topical Losartan: Practical Guidance for Clinical Trials in the Prevention and Treatment of Corneal Scarring Fibrosis and Other Eye Diseases and Disorders.

Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics
2023

Inherited causes of exocrine pancreatic insufficiency in pediatric patients: clinical presentation and laboratory testing.

Critical reviews in clinical laboratory sciences
2023

Update of penetrance estimates in Birt-Hogg-Dubé syndrome.

Journal of medical genetics
2023

PPAR δ Agonism Ameliorates Renal Fibrosis in an Alport Syndrome Mouse Model.

Kidney360
2022

[Risk and protective factors for colorectal cancer].

La Revue du praticien
2023

Interstitial lung disease in autoinflammatory disease in childhood: A systematic review of the literature.

Pediatric pulmonology
2022

Luspatercept: A New Tool for the Treatment of Anemia Related to β-Thalassemia, Myelodysplastic Syndromes and Primary Myelofibrosis.

Diseases (Basel, Switzerland)
2022

Late Presentation of Dyskeratosis Congenita: Germline Predisposition to Adult-Onset Secondary Acute Myeloid Leukemia.

Hematology reports
2022

PUNCTATE INNER CHOROIDOPATHY-LIKE REACTIONS IN UNRELATED RETINAL DISEASES.

Retina (Philadelphia, Pa.)
2022

Activation of Stimulator of IFN Genes (STING) Causes Proteinuria and Contributes to Glomerular Diseases.

Journal of the American Society of Nephrology : JASN
2024

Recurrent orbital inflammation associated with VEXAS syndrome.

Orbit (Amsterdam, Netherlands)
2022

EHBP1L1 Frameshift Deletion in English Springer Spaniel Dogs with Dyserythropoietic Anemia and Myopathy Syndrome (DAMS) or Neonatal Losses.

Genes
2023

Hereditary fibrosing poikiloderma (POIKTMP syndrome) report of a new mutation and review of the literature.

Pediatric dermatology
2022

Prevalence of hereditary tubulointerstitial kidney diseases in the German Chronic Kidney Disease study.

European journal of human genetics : EJHG
2022

Myocardial Scintigraphy in Diagnosing Cardiac Transthyretin Amyloidosis.

Texas Heart Institute journal
2022

Novel APOB nonsense variant related to familial hypobetalipoproteinemia and hepatic steatosis: A case report and review.

Journal of clinical lipidology
2022

Keratopathy in Noonan Syndrome.

Cornea
2022

Potential Renal Damage Biomarkers in Alport Syndrome-A Review of the Literature.

International journal of molecular sciences
2022

Hepatic Necrosis Mimicking Infiltrative Masses in Acute Budd-Chiari Syndrome With Hereditary Protein C Deficiency.

ACG case reports journal
2022

Novel Keap1-Nrf2 Protein-Protein Interaction Inhibitor UBE-1099 Ameliorates Progressive Phenotype in Alport Syndrome Mouse Model.

Kidney360
2022

Primary myelofibrosis with thrombophilia as first symptom combined with thalassemia and Gilbert syndrome: A case report.

World journal of clinical cases
2022

Microvascular neural blood flow assessment for a chronic nerve compression neuropathy mouse model by fluorescein angiography.

Neurological research
2022

Association Between Deleterious SCN5A Variants and Ventricular Septal Defect in Young Patients With Brugada Syndrome.

JACC. Clinical electrophysiology
2022

Inherited pancreatic exocrine insufficiency and pancreatitis: When children transition to adult care.

Best practice &amp; research. Clinical gastroenterology
2022

Rapidly Progressing to ESRD in an Individual with Coexisting ADPKD and Masked Klinefelter and Gitelman Syndromes.

Genes
2022

Involvement of muscle satellite cell dysfunction in neuromuscular disorders: Expanding the portfolio of satellite cell-opathies.

European journal of translational myology
2022

Anti-microRNA-21 Therapy on Top of ACE Inhibition Delays Renal Failure in Alport Syndrome Mouse Models.

Cells
2022

A Neutralizing IL-11 Antibody Improves Renal Function and Increases Lifespan in a Mouse Model of Alport Syndrome.

Journal of the American Society of Nephrology : JASN
2023

Enhanced S-Cone Syndrome Masquerading as TORCH in an Infant and a Toddler.

Ocular immunology and inflammation
2021

Factors for severe outcomes following SARS-CoV-2 infection in people with cystic fibrosis in Europe.

ERJ open research
2022

Intravital imaging reveals glomerular capillary distension and endothelial and immune cell activation early in Alport syndrome.

JCI insight
2022

Histopathology of the Conduction System in Long QT Syndrome.

Fetal and pediatric pathology
2021

Tale of two nephropathies; co-occurring Alport syndrome and IgA nephropathy, a case report.

BMC nephrology
2021

Creation of X-linked Alport syndrome rat model with Col4a5 deficiency.

Scientific reports
2021

Lung cancer is also a hereditary disease.

European respiratory review : an official journal of the European Respiratory Society
2021

Screening strategy for gastrointestinal and hepatopancreatobiliary cancers in cystic fibrosis.

World journal of gastrointestinal oncology
2021

Spontaneous chromosomal instability in peripheral blood lymphocytes from two molecularly confirmed Italian patients with Hereditary Fibrosis Poikiloderma: insights into cancer predisposition.

Genetics and molecular biology
2021

WNT2 activation through proximal germline deletion predisposes to small intestinal neuroendocrine tumors and intestinal adenocarcinomas.

Human molecular genetics
2022

Amiodarone-induced multiple organ damage in an Alström syndrome patient with end-stage renal disease and hepatic cirrhosis.

CEN case reports
2021

Organoprotective Effects of Spironolactone on Top of Ramipril Therapy in a Mouse Model for Alport Syndrome.

Journal of clinical medicine
2021

Pancreas in Hereditary Syndromes: Cross-sectional Imaging Spectrum.

Radiographics : a review publication of the Radiological Society of North America, Inc
2021

CRISPR-Cas9 for treating hereditary diseases.

Progress in molecular biology and translational science
2021

Function and Regulation of the Epithelial Na+ Channel ENaC.

Comprehensive Physiology
2021

Incidence of SARS-CoV-2 in people with cystic fibrosis in Europe between February and June 2020.

Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society
2021

Novel GUCY2C variant causing familial diarrhea in a Mennonite kindred and a potential therapeutic approach.

American journal of medical genetics. Part A
2021

A ZFYVE19 gene mutation associated with neonatal cholestasis and cilia dysfunction: case report with a novel pathogenic variant.

Orphanet journal of rare diseases
2021

Recognizable Patterns of Submacular Fibrosis in Enhanced S-Cone Syndrome.

Ophthalmology. Retina
2021

Metformin ameliorates the severity of experimental Alport syndrome.

Scientific reports
2021

Life-Long Hyperbilirubinemia Exposure and Bilirubin Priming Prevent In Vitro Metabolic Damage.

Frontiers in pharmacology
2021

HMGB-1 and TGFβ-1 highlight immuno-inflammatory and fibrotic processes before proteinuria onset in pediatric patients with Alport syndrome.

Journal of nephrology
2021

Luminal Gastrointestinal Manifestations of Cystic Fibrosis.

Current gastroenterology reports
2021

Kidney-accumulating olmesartan-loaded nanomicelles ameliorate the organ damage in a murine model of Alport syndrome.

International journal of pharmaceutics
2021

Inherited skin disorders presenting with poikiloderma.

International journal of dermatology
2021

The role of discoidin domain receptor 2 in the renal dysfunction of alport syndrome mouse model.

Renal failure
2021

Epidemiology, pathogenesis, diagnosis, surveillance, and management of hepatocellular carcinoma associated with vascular liver disease.

The Kaohsiung journal of medical sciences
2021

Pulmonary Abnormalities in Liver Disease: Relevance to Transplantation and Outcome.

Hepatology (Baltimore, Md.)
2021

Diseases of the corneal endothelium.

Experimental eye research
2021

Diagnosis and management of secondary causes of steatohepatitis.

Journal of hepatology
2021

Epigenomic Profiles of African-American Transthyretin Val122Ile Carriers Reveals Putatively Dysregulated Amyloid Mechanisms.

Circulation. Genomic and precision medicine
2021

Activated KCNQ1 channel promotes fibrogenic response in hereditary gingival fibromatosis via clustering and activation of Ras.

Journal of periodontal research
2021

Discoidin domain receptor 1 activation links extracellular matrix to podocyte lipotoxicity in Alport syndrome.

EBioMedicine
2021

Nerve wrapping for recurrent compression neuropathy: A systematic review.

Journal of plastic, reconstructive &amp; aesthetic surgery : JPRAS
2021

Interstitial Pneumonia Secondary to Hermansky-Pudlak Syndrome Type 4 Treated with Different Antifibrotic Agents.

Internal medicine (Tokyo, Japan)
2020

Combined liver-kidney transplantation for rare diseases.

World journal of hepatology
2021

Pharmacological inhibition of Vanin-1 is not protective in models of acute and chronic kidney disease.

American journal of physiology. Renal physiology
2021

Hereditary gingival fibromatosis in children: a systematic review of the literature.

Clinical oral investigations
2021

Contact lens induced bacterial keratitis in LCD II: Management and multimodal imaging: a case report and review of literature.

European journal of ophthalmology
2020

[Management of Primary Ciliary Dyskinesia].

Pneumologie (Stuttgart, Germany)
2021

Incidence and Natural History of Retinochoroidal Neovascularization in Enhanced S-Cone Syndrome.

American journal of ophthalmology
2021

Hereditary Palpebro-Gingival Fibrosis Syndrome.

Ophthalmic plastic and reconstructive surgery
2020

Cutaneous Leiomyoma Mimicking a Keloid.

Acta dermatovenerologica Croatica : ADC
2020

A 34-year-old Japanese patient exhibiting NBAS deficiency with a novel mutation and extended phenotypic variation.

European journal of medical genetics
2020

FAM111 protease activity undermines cellular fitness and is amplified by gain-of-function mutations in human disease.

EMBO reports
2020

The recurrent TUBB3 Gly98Ser substitution is the first described to inconsistently result in CFEOM3.

American journal of medical genetics. Part A
2021

Enhanced S-Cone Syndrome: Spectrum of Clinical, Imaging, Electrophysiologic, and Genetic Findings in a Retrospective Case Series of 56 Patients.

Ophthalmology. Retina
2021

Histopathologic features of breast cancer in Li-Fraumeni syndrome.

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
2020

Sclerodermalike syndromes: Great imitators.

Clinics in dermatology
2020

Liver cirrhosis in a patient with hepatic hereditary hemorrhagic telangiectasia and Budd-Chiari syndrome: a case report.

BMC gastroenterology
2020

First proof of association between autoimmune polyglandular syndrome and multiple endocrine neoplasia in humans.

Endocrine journal
2020

Diagnosis of Non-Alcoholic Fatty Liver Disease (NAFLD) Is Independently Associated with Cardiovascular Risk in a Large Austrian Screening Cohort.

Journal of clinical medicine
2020

SPTB related spherocytosis in a three-generation family presenting with kidney failure in adulthood due to co-occurrence of UMOD disease causing variant.

Nefrologia
2020

CG200745, a Novel HDAC Inhibitor, Attenuates Kidney Fibrosis in a Murine Model of Alport Syndrome.

International journal of molecular sciences
2019

An Unusual Case of Congenital Hepatic Fibrosis with Retinitis Pigmentosa.

Cureus
2019

Autosomal recessive Alport syndrome caused by a novel COL4A4 splice site mutation: a case report.

Croatian medical journal
2019

[Venous wall weackness pathogenesis in varicose vein disease].

Khirurgiia
2019

Severe anemia caused by hereditary hemorrhagic telangiectasia in a patient with Sjögren's syndrome and primary biliary cirrhosis.

Chinese medical journal
2019

Family of hereditary fibrosing poikiloderma with tendon contractures, myopathy and pulmonary fibrosis caused by a novel FAM111B mutation.

The Journal of dermatology
2019

Olmesartan Attenuates Kidney Fibrosis in a Murine Model of Alport Syndrome by Suppressing Tubular Expression of TGFβ.

International journal of molecular sciences
2019

The effect of dicarbonyl stress on the development of kidney dysfunction in metabolic syndrome - a transcriptomic and proteomic approach.

Nutrition &amp; metabolism
2019

Two Specific Sulfatide Species Are Dysregulated during Renal Development in a Mouse Model of Alport Syndrome.

Lipids
2019

New therapeutic options for Alport syndrome.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
2019

An Original Description of Granulomatous Liver Cirrhosis in Blau Syndrome.

Digestive diseases and sciences
2019

Osteopontin Promotes Left Ventricular Diastolic Dysfunction Through a Mitochondrial Pathway.

Journal of the American College of Cardiology
2019

Amyloid in parenchymal organs in gelsolin (AGel) amyloidosis.

Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis
2019

Unexpected Rapid Increase in the Burden of NAFLD in China From 2008 to 2018: A Systematic Review and Meta-Analysis.

Hepatology (Baltimore, Md.)
2019

John's story - living with hereditary haemochromatosis.

Rural and remote health
2019

Mutation in FAM111B Causes Hereditary Fibrosing Poikiloderma with Tendon Contracture, Myopathy, and Pulmonary Fibrosis.

Acta dermato-venereologica
2019

Pulmonary alveolar proteinosis.

Nature reviews. Disease primers
2019

Significance of UGT1A1*28 Genotype in Patients with Advanced Liver Injury Caused By Chronic Hepatitis C.

Journal of medical biochemistry
2019

Dysregulated Expression of microRNA-21 and Disease-Related Genes in Human Patients and in a Mouse Model of Alport Syndrome.

Human gene therapy
2019

Iron and liver fibrosis: Mechanistic and clinical aspects.

World journal of gastroenterology
2019

Lev's Syndrome: A rare case of progressive cardiac conduction disorder presenting to the emergency department.

The American journal of emergency medicine
2018

Hemochromatosis - modern condition of the problem.

Terapevticheskii arkhiv
2019

Bleeding assessment in female patients with the Hermansky-Pudlak syndrome-A case series.

European journal of haematology
2018

Orthotopic Liver Transplantation for Hereditary Hemorrhagic Telangiectasia and MEN Type I Syndrome - Case Report and Review of Literature.

Chirurgia (Bucharest, Romania : 1990)
2019

DNA-Encoded Library-Derived DDR1 Inhibitor Prevents Fibrosis and Renal Function Loss in a Genetic Mouse Model of Alport Syndrome.

ACS chemical biology
2019

Abnormal Expression of miR-21 in Kidney Tissue of Dogs With X-Linked Hereditary Nephropathy: A Canine Model of Chronic Kidney Disease.

Veterinary pathology
2018

Role of TGF-β in Alcohol-Induced Liver Disease.

Advances in experimental medicine and biology
2018

Hydroxypropyl-β-cyclodextrin protects from kidney disease in experimental Alport syndrome and focal segmental glomerulosclerosis.

Kidney international
2018

HDAC inhibition improves autophagic and lysosomal function to prevent loss of subcutaneous fat in a mouse model of Cockayne syndrome.

Science translational medicine
2018

Molecular Study of Nephronophthisis in 7 Unrelated Pakistani Families.

Iranian journal of kidney diseases
2018

Respiratory care in familial dysautonomia: Systematic review and expert consensus recommendations.

Respiratory medicine
2018

Intralesional Deoxycholic Acid Treatment for Fibrofatty Residua of Involuted Infantile Hemangiomas: A Novel Therapeutic Approach.

JAMA dermatology
2018

Lysyl oxidase like-2 contributes to renal fibrosis in Col4α3/Alport mice.

Kidney international
2018

Pathologic Features of Hereditary Cholestatic Diseases.

Surgical pathology clinics
2018

Hermansky-Pudlak syndrome type 2 manifests with fibrosing lung disease early in childhood.

Orphanet journal of rare diseases
2018

A case of hereditary fibrosing poikiloderma with tendon contractures, myopathy and pulmonary fibrosis (POIKTMP) with the emphasis on cutaneous histopathological findings.

Journal of the European Academy of Dermatology and Venereology : JEADV
2018

Acquired Elliptocytosis as a Manifestation of Myelodysplastic Syndrome Associated with Deletion of Chromosome 20q.

Case reports in hematology
2018

Coexistence of keloids and pilomatricoma in a patient with Rubinstein-Taybi syndrome.

Dermatology online journal
2018

Alport's syndrome with focal segmental glomerulosclerosis lesion - Pattern to recognize.

Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia
2017

Mildly Elevated Liver Transaminase Levels: Causes and Evaluation.

American family physician
2017

Amniotic fluid stem cell-derived vesicles protect from VEGF-induced endothelial damage.

Scientific reports
2017

Differences in UGT1A1 gene mutations and pathological liver changes between Chinese patients with Gilbert syndrome and Crigler-Najjar syndrome type II.

Medicine
2017

An inducible mouse model of podocin-mutation-related nephrotic syndrome.

PloS one
2017

A TUBB6 mutation is associated with autosomal dominant non-progressive congenital facial palsy, bilateral ptosis and velopharyngeal dysfunction.

Human molecular genetics
2018

STAT3 inhibition attenuates the progressive phenotypes of Alport syndrome mouse model.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
2017

Bromide supplementation exacerbated the renal dysfunction, injury and fibrosis in a mouse model of Alport syndrome.

PloS one
2018

The activin receptor is stimulated in the skeleton, vasculature, heart, and kidney during chronic kidney disease.

Kidney international
2017

Hereditary Lymphedema of the Leg - A Case Report.

Open access Macedonian journal of medical sciences
2017

The role of GLIS3 in thyroid disease as part of a multisystem disorder.

Best practice &amp; research. Clinical endocrinology &amp; metabolism
2017

Liver Fibrosis Associated With Crigler-Najjar Syndrome in a Compound Heterozygote: A Case Report.

Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Síndrome de poiquilodermia fibrosante hereditária-contraturas-miopatia-fibrose pulmonar.

É de uma associação que acompanha esta doença? Fale com a gente →

Comunidades

Grupos ativos de quem convive com esta doença aqui no Raras

Ainda não existe comunidade no Raras para Síndrome de poiquilodermia fibrosante hereditária-contraturas-miopatia-fibrose pulmonar

Pacientes, familiares e cuidadores se organizam em comunidades pra compartilhar experiências, fazer perguntas e se apoiar. Você pode ser o primeiro.

Tire suas dúvidas

Perguntas, dicas e experiências compartilhadas aqui na página

Participe da discussão

Faça login para postar dúvidas, compartilhar experiências e interagir com especialistas.

Fazer login

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Referências e fontes

Bases de dados externas citadas neste artigo

Publicações científicas

Artigos indexados no PubMed ligados a esta doença no grafo RarasNet — título, periódico e PMID direto da fonte, sem intermediação de IA.

  1. A Diagnostic Dilemma: Concurrent Diagnosis of Cystic Fibrosis and Definitive Kabuki Syndrome Type 1.
    International journal of molecular sciences· 2026· PMID 41828725mais citado
  2. Protective role of early Tnfsf15 upregulation in limiting glomerular injury and proteinuria in experimental Alport Syndrome.
    Journal of pharmacological sciences· 2026· PMID 41672640mais citado
  3. Horns, nails, and leaky kidneys: A rare case of congenital nephrotic syndrome.
    Clinical nephrology. Case studies· 2026· PMID 41782702mais citado
  4. Alport Syndrome is a Partial Tubulointerstitial Disease of the Kidney.
    Kidney international reports· 2026· PMID 41531438mais citado
  5. Non-Syndromic Hereditary Gingival Fibromatosis Driven by Chymase Deficiency Is Attenuated by Verteporfin-Loaded Exosomes.
    Journal of clinical periodontology· 2026· PMID 41386781mais citado
  6. Midfacial toddler excoriation syndrome (MiTES): case series, diagnostic criteria and evidence for a pathogenic mechanism.
    Br J Dermatol· 2024· PMID 38591490recente
  7. [Lung involvement in autoinflammatory diseases].
    Rev Mal Respir· 2024· PMID 38040588recente
  8. Interstitial lung disease in autoinflammatory disease in childhood: A systematic review of the literature.
    Pediatr Pulmonol· 2023· PMID 36314652recente
  9. Recurrent orbital inflammation associated with VEXAS syndrome.
    Orbit· 2024· PMID 36168114recente
  10. EHBP1L1 Frameshift Deletion in English Springer Spaniel Dogs with Dyserythropoietic Anemia and Myopathy Syndrome (DAMS) or Neonatal Losses.
    Genes (Basel)· 2022· PMID 36140701recente

Bases de dados e fontes oficiais

Identificadores e referências canônicas usadas para montar este verbete.

  1. ORPHA:221043(Orphanet)
  2. OMIM OMIM:615704(OMIM)
  3. MONDO:0014310(MONDO)
  4. GARD:13218(GARD (NIH))
  5. Variantes catalogadas(ClinVar)
  6. Busca completa no PubMed(PubMed)
  7. Q55784774(Wikidata)

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Síndrome de poiquilodermia fibrosante hereditária-contraturas-miopatia-fibrose pulmonar
Compêndio · Raras BR

Síndrome de poiquilodermia fibrosante hereditária-contraturas-miopatia-fibrose pulmonar

ORPHA:221043 · MONDO:0014310
Prevalência
<1 / 1 000 000
Casos
15 casos conhecidos
Herança
Autosomal dominant
CID-10
Q82.8 · Outras malformações congênitas especificadas da pele
Início
Infancy
Prevalência
0.0 (Worldwide)
MedGen
UMLS
C3810325
Wikidata
DiscussaoAtiva

Nenhuma novidade ainda. O agente esta monitorando.

0membros
0novidades